It’s been three full months of record-high tariffs, and yet rolling 12-month overall inflation came in at 2.7% in July, the same percentage rate as June, according to last week’s Bureau of Labor Statistics (BLS) inflation report. Core inflation (CPI), which excludes food and oil, rose 3.1% in July, up from 2.9% in June.
Florida Congressman Daniel Webster’s ‘USA Act’, introduced in August, amends the Science portion of the ‘CHIPS & Sciences Act’ to improve U.S. role in standards setting.
The initial report of the CPA/PSSI China Space Security Initiative (CSSI) details how Beijing is working to penetrate and control the space sectors of more than 120 countries through hundreds of ostensibly commercial agreements, via state-controlled Chinese companies that, in effect, act as fronts for the People’s Liberation Army (PLA).
The domestic polysilicon supply remains a national security imperative for the United States for many reasons including: China’s link to forced labor and human rights abuses; a globalized Chinese Communist Party-subsidized solar industry leading to overcapacity and export dumping; and the limitations of U.S. trade remedies to help, deep into the solar supply chain.
Investigation follows formal petitions filed last month by The Alliance for American Solar Manufacturing and Trade, in response to market manipulation driven by predominantly Chinese-owned manufacturing companies operating in Indonesia, and Laos, as well as those headquartered in India.
Closing de minimis means that commercial shipments from overseas vendors must enter the United States through standard customs procedures, submit full import documentation, and pay applicable duties and taxes—a long-overdue reform to restore order and accountability to America’s trade system.
CPA submitted formal comments to the Federal Communications Commission (FCC) this week supporting its proposed rule to increase transparency regarding foreign adversary control of smart devices and appliances.
The African Growth and Opportunity Act (AGOA), enacted in 2000, was designed to promote economic development and democratic reform in Sub-Saharan Africa by granting duty-free access to the U.S. market for thousands of products.
America’s generic drug supply is at a crisis point. As detailed in previous reports, the United States is dangerously reliant on a high-risk imported drug supply, and today’s widespread drug shortages stem not from shipping delays or unexpected demand—but from a collapse in domestic production.